Asia Pacific Centre for Animal Health, Melbourne Veterinary School, Faculty of Science, The University of Melbourne, Parkville, Victoria, Australia.
PLoS One. 2024 Aug 23;19(8):e0292908. doi: 10.1371/journal.pone.0292908. eCollection 2024.
This cross-sectional study surveyed veterinarians and facility managers to characterise the use of antimicrobials in laboratory rodent facilities within Australia and New Zealand. Most facilities (71%) reported routine administration of antimicrobials. The indications for antibiotic use reflected those described in publications and differed significantly to reasons for use in non-laboratory animals. Antimicrobials used include those of critical importance to human health, and access to these drugs is unregulated, as prescription-only classes are ordered through research catalogues, without human or veterinary physician prescriptions. The ways in which antimicrobials are used in Australian and New Zealand rodent facilities are likely contributing to antimicrobial resistance within rodent populations, particularly as they are largely administered in drinking water, risking subtherapeutic dosing. Much antimicrobial use reported is unnecessary and could be replaced with changes to husbandry and handling. The generation of resistance in both pathogenic and commensal microbes may also represent a work health and safety issue for humans working with these animals. Reported disposal of antimicrobials included discharge into wastewater, without inactivation, and some respondents reported disposal of substrate, or soiled bedding, nesting material, and disposable enrichment items, from treated animals and medicated feed into landfill, without prior inactivation. Environmental contamination with resistant microbes and antimicrobials is a significant driver of antimicrobial resistance. As such, significant opportunities exist to implement judicious and responsible use of antimicrobials within research rodent facilities in Australia and New Zealand, with a particular focus on instituting aseptic surgery, optimising dosing regimens, and inactivation of medicated water and substrate before disposal.
本横断面研究调查了澳大利亚和新西兰的兽医和设施管理人员,以了解实验室啮齿动物设施中抗菌药物的使用情况。大多数设施(71%)报告常规使用抗菌药物。抗生素使用的指征反映了出版物中描述的指征,与非实验室动物的使用原因有显著差异。使用的抗菌药物包括对人类健康至关重要的抗菌药物,而且这些药物的使用不受监管,因为处方药类通过研究目录订购,无需人类或兽医医生的处方。澳大利亚和新西兰啮齿动物设施中抗菌药物的使用方式可能导致啮齿动物种群中的抗菌药物耐药性,特别是因为它们主要在饮水中使用,存在治疗剂量不足的风险。报告的许多抗菌药物使用是不必要的,可以通过改变饲养和处理方式来替代。致病性和共生微生物产生耐药性也可能代表与这些动物一起工作的人类的工作健康和安全问题。报告的抗菌药物处置包括未经失活而排放到废水中,一些受访者报告了从处理过的动物和经药物处理的饲料中处置基质或污染的床上用品、筑巢材料和一次性丰容物品到垃圾填埋场,而没有事先失活。具有耐药微生物和抗菌药物的环境污染是抗菌药物耐药性的一个重要驱动因素。因此,在澳大利亚和新西兰的研究啮齿动物设施中,有很大的机会实施合理和负责任的抗菌药物使用,特别是要注重无菌手术、优化剂量方案,并在处置前对含药水和基质进行失活。